Wordt geladen...
Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones
Despite over 50 years of inhaled beta-agonists and corticosteroids as the default management or rescue drugs for asthma, recent research suggests that new therapeutic options are likely to emerge. This belief stems from both an improved understanding of what causes and regulates airway smooth muscle...
Bewaard in:
Gepubliceerd in: | Pharmacol Ther |
---|---|
Hoofdauteurs: | , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4942340/ https://ncbi.nlm.nih.gov/pubmed/27113408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2016.04.002 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|